期刊文献+

Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells 被引量:2

Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells
下载PDF
导出
摘要 AIM: To present an approach for selectively killing retrovirus-infected cells that combines the toxicity of Pseudomonas exotoxin (PE) and the presence of reverse transcriptase (RT) in infected cells. METHODS: PE antisense toxin RNA has palindromic stem loops at its 5' and 3' ends enabling self-primed generation of cDNA in the presence of RT. The RT activity expressed in retrovirus-infected cells converts "antisense-toxin-RNA" into a lethal toxin gene exclusively in these cells. RESULTS: Using cotransfection studies with PE-expressing RNAs and β-gal expressing reporter plasmids, we show that, in HepG2 and HepG2.2.15 hepatoma cells as well as in duck hepatitis B virus (DHBV) infected cells, HBV or DHBV-polymerase reverse transcribe a lethal cDNA copy of an antisense toxin RNA, which is composed of sequences complementary to a PE gene and eukaryotic transcription and translation signals. CONCLUSION: This finding may have important implications as a novel therapeutic strategy aimed at the elimination of HBV infection. AIM: To present an approach for selectively killing retrovirus-infected cells that combines the toxicity of Pseudomonas exotoxin (PE) and the presence of reverse transcriptase (RT) in infected cells. METHODS: PE antisense toxin RNA has palindromic stem loops at its 5' and 3' ends enabling self-primed generation of cDNA in the presence of RT. The RT activity expressed in retrovirus-infected cells converts "antisense-toxin-RNA" into a lethal toxin gene exclusively in these cells. RESULTS: Using cotransfection studies with PE-expressing RNAs and β-gal expressing reporter plasmids, we show that, in HepG2 and HepG2.2.15 hepatoma cells as well as in duck hepatitis B virus (DHBV) infected cells, HBV or DHBV-polymerase reverse transcribe a lethal cDNA copy of an antisense toxin RNA, which is composed of sequences complementary to a PE gene and eukaryotic transcription and translation signals. CONCLUSION: This finding may have important implications as a novel therapeutic strategy aimed at the elimination of HBV infection.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第18期2810-2817,共8页 世界胃肠病学杂志(英文版)
关键词 Gene therapy Pseudomonas exotoxin RETROVIRUS Reverse transcription 假单胞菌 外毒素 基因治疗 乙型肝炎病毒
  • 相关文献

参考文献1

二级参考文献11

  • 1Naoya Igaki,Miyuki Nakaji,Rintarou Moriguchi,Hiroyuki Akiyama,Fumihiko Tamada,Munetada Oimomi,Takeo Goto.An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients[J].Journal of Gastroenterology.2003(10)
  • 2Isogawa M,Furuichi Y,Chisari FV.Oscillating CD8(+) T cell effector functions after antigen recognition in the liver[].Immunity.2005
  • 3Ganem D,Prince AM.Hepatitis B virus infection--natural history and clinical consequences[].The New England Journal of Medicine.2004
  • 4Lai CL,Chien RN,Leung NW,Chang TT,Guan R,Tai DI,Ng KY,Wu PC,Dent JC,Barber J,Stephenson SL,Gray DF.A one- year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group[].N Engl J Med.1998
  • 5Angus P,Vaughan R,Xiong S,Yang H,Delaney W,Gibbs C,Brosgart C,Colledge D,Edwards R,Ayres A,Bartholomeusz A,Locarnini S.Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase[].Gastroenterology.2003
  • 6Marcellin P,Chang TT,Lim SG,Tong MJ,Sievert W,Shiffman ML,Jeffers L,Goodman Z,Wulfsohn MS,Xiong S,Fry J,Brosgart CL.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B[].N Engl J Med.2003
  • 7Stoop JN,van der Molen RG,Baan CC,van der Laan LJ,Kuipers EJ,Kusters JG,Janssen HL.Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[].Hepatology.2005
  • 8Ghany MG,Ayola B,Villamil FG,Gish RG,Rojter S,Vierling JM,Lok AS.Hepatitis B virus S mutants in liver transplantrecipients who were reinfected despite hepatitis B immune globulin prophylaxis[].Hepatology.1998
  • 9Rehermann B,Pasquinelli C,Mosier SM,Chisari FV.Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection[].The Journal of Clinical Investigation.1995
  • 10Carman WF,Trautwein C,van Deursen FJ,Colman K,Dornan E,McIntyre G,Waters J,Kliem V,Muller R,Thomas HC,Manns MP.Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis[].Hepatology.1996

共引文献49

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部